146 related articles for article (PubMed ID: 36858343)
21. Small proline rich protein 2a in benign and malignant liver disease.
Mizuguchi Y; Isse K; Specht S; Lunz JG; Corbitt N; Takizawa T; Demetris AJ
Hepatology; 2014 Mar; 59(3):1130-43. PubMed ID: 24123265
[TBL] [Abstract][Full Text] [Related]
22. Combination therapies for targeting FGFR2 fusions in cholangiocarcinoma.
Saborowski A; Vogel A; Segatto O
Trends Cancer; 2022 Feb; 8(2):83-86. PubMed ID: 34840108
[TBL] [Abstract][Full Text] [Related]
23. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
24. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
25. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.
Techasen A; Namwat N; Loilome W; Bungkanjana P; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Med Oncol; 2012 Dec; 29(5):3083-91. PubMed ID: 22903530
[TBL] [Abstract][Full Text] [Related]
27. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
[TBL] [Abstract][Full Text] [Related]
28. Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis.
Fu Y; Shen K; Wang H; Wang S; Wang X; Zhu L; Zheng Y; Zou T; Ci H; Dong Q; Qin LX
Signal Transduct Target Ther; 2024 Mar; 9(1):63. PubMed ID: 38453934
[TBL] [Abstract][Full Text] [Related]
29. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6.
Li S; Zheng H; Mao AP; Zhong B; Li Y; Liu Y; Gao Y; Ran Y; Tien P; Shu HB
J Biol Chem; 2010 Feb; 285(7):4291-7. PubMed ID: 19996094
[TBL] [Abstract][Full Text] [Related]
30. Histopathological evidence of intrahepatic cholangiocarcinoma occurring in ductal plate malformation: A clinicopathologic study of 5 cases.
Wang Q; Xu Y; Wang SM; Hu AY; Pan YC; Zhang SH
Ann Diagn Pathol; 2021 Dec; 55():151828. PubMed ID: 34571341
[TBL] [Abstract][Full Text] [Related]
31. The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression.
Mancarella S; Serino G; Coletta S; Armentano R; Dituri F; Ardito F; Ruzzenente A; Fabregat I; Giannelli G
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457006
[TBL] [Abstract][Full Text] [Related]
32. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y
Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895
[TBL] [Abstract][Full Text] [Related]
33. Matricellular proteins in intrahepatic cholangiocarcinoma.
Sirica AE
Adv Cancer Res; 2022; 156():249-281. PubMed ID: 35961702
[TBL] [Abstract][Full Text] [Related]
34. Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.
Xiong F; Wang D; Xiong W; Wang X; Huang WH; Wu GH; Liu WZ; Wang Q; Chen JS; Kuai YY; Wang B; Chen YJ
J Exp Clin Cancer Res; 2024 May; 43(1):152. PubMed ID: 38812060
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma.
Mammola CL; Vetuschi A; Pannarale L; Sferra R; Mancinelli R
Eur J Histochem; 2018 Nov; 62(4):. PubMed ID: 30504933
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
37. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.
Sirica AE
Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):44-54. PubMed ID: 22143274
[TBL] [Abstract][Full Text] [Related]
38. GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma.
Deng X; Jiang P; Chen J; Li J; Li D; He Y; Jiang Y; Zhang Y; Xu S; Li X; Wang S; Tian F
Cell Death Dis; 2020 Oct; 11(10):860. PubMed ID: 33060563
[TBL] [Abstract][Full Text] [Related]
39. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
40. miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma.
Lixin S; Wei S; Haibin S; Qingfu L; Tiemin P
Mol Carcinog; 2020 Dec; 59(12):1371-1381. PubMed ID: 33052627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
